EGFR and lung adenocarcinoma: While meningiomas are the most common recipients, this route of recurrence has not been reported in epidermal growth factor receptor (EGFR)-mutated lung adenocarcinoma. A 74-year-old female patient, who had remained disease-free for 14 years after undergoing right upper lobectomy for stage IA (pT1N0M0) lung adenocarcinoma, presented with headache and vomiting.